• (R)-MG132 Proteasome Control Workflow

  2026-08-29

  Use (R)-MG132 as a stereochemical negative control to separate genuine proteasome-dependent biology from solvent, cytotoxicity, and off-target effects. This workflow shows how to apply the MG-132 enantiomer when studying HNRNPU stability, lactylation, PHGDH expression, and serine-metabolism phenotypes.

• Wortmannin: Reading Autophagy Through PI3K

  2026-08-28

  Wortmannin is a powerful PI3K inhibitor for dissecting autophagy, host-pathogen signaling, and cancer biology. This guide focuses on how to interpret pathway perturbation rigorously, distinguishing PI3K-dependent effects from flux, toxicity, and off-target mechanisms.

• Metformin Hydrochloride in Immunometabolism Assays

  2026-08-28

  Use Metformin Hydrochloride to connect metabolic regulation with cytokine biology in standardized whole-blood experiments. This workflow emphasizes aqueous preparation, donor-aware controls, concentration-response design, and clear separation between immune readouts and direct hepatic metabolism models.

• Cell Senescence β-Galactosidase Staining Kit Workflow

  2026-08-28

  Build a practical cellular senescence assay around SA-β-Gal staining, from polystyrene-compatible sample preparation to image-based quantification. The workflow also shows how the assay can test senescence induced by HPV-16 E6 inhibition while distinguishing a useful phenotype readout from proof of mechanism.

• Gramine: A Mechanistic Route into TNBC Ferroptosis

  2026-08-27

  Gramine, also known as 1-(1H-indol-3-yl)-N,N-dimethylmethanamine, is emerging as a mechanism-forward tool for triple-negative breast cancer research. By connecting CUL3–MTDH regulation with ferroptosis, the compound offers translational researchers a way to move beyond viability assays toward target engagement, pathway validation, and biomarker-led experimental design.

• Plk1, p31comet, and Mitotic Checkpoint Disassembly

  2026-08-26

  The reference study identifies Polo-like kinase 1 as a direct regulator of p31comet, showing that Plk1 phosphorylation at S102 suppresses p31comet–TRIP13-mediated disassembly of mitotic checkpoint complexes. This mechanism explains how cells avoid premature checkpoint silencing during mitosis and provides a useful framework for interpreting experiments that perturb mitotic kinase signaling.

• TNF-alpha Recombinant Murine Protein in Apoptosis Assays

  2026-08-26

  Explore how TNF-alpha recombinant murine protein can function as a defined apoptosis stimulus and an interpretive control alongside emerging RNA polymerase II death biology. This guide connects receptor signaling, assay design, product specifications, and mechanistic limitations.

• Deuterium-Labeled Degarelix: Synthesis and Significance

  2026-08-26

  The reference study reports a 13-step route to deuterium-labeled degarelix acetate with D2O/D3PO4-mediated preparation of a [D7]naphthylalanine building block and a 14% overall yield. The labeled antagonist was designed as an internal standard for absorption, distribution, metabolism, and excretion studies, providing a practical analytical foundation for quantitative GnRH antagonist research.

• Epacadostat (INCB024360) Assay Workflow

  2026-08-25

  Build more informative IDO1 assays by pairing Epacadostat with standardized whole-blood stimulation, kynurenine measurements, cytokine profiling, and T-cell functional readouts. This workflow helps distinguish direct IDO1 inhibition from donor variability, solvent effects, and nonspecific immune suppression.

• Daphnepedunin A Targets Cdc42 in Kidney Fibrosis

  2026-08-24

  The reference study identifies daphnepedunin A, a diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic compound that acts through Cdc42-mediated GSK-3β/β-catenin signaling. Its combination of chemical discovery, thermal proteome profiling, cell models, and unilateral ureteral obstruction experiments provides a useful framework for evaluating Cdc42 as a therapeutic target in chronic kidney disease.

• Hepatic sEH–Nrf2 Signaling in Osteoporosis

  2026-08-24

  The reference study identifies a liver–bone signaling axis in which hepatic soluble epoxide hydrolase alters circulating 14,15-EET and 14,15-DHET, suppressing Nrf2 activity and promoting osteoclast differentiation. Its combination of patient samples, ovariectomy-induced osteoporosis, liver-specific sEH manipulation, and in vitro assays provides a mechanistic framework for studying redox imbalance and bone loss.

• Leupeptin: From Protease Control to Translation

  2026-08-23

  Leupeptin hemisulfate salt is more than a general laboratory inhibitor: its reversible, competitive control of serine and cysteine proteases can improve experimental interpretation across protein degradation, viral replication, and autophagy studies. This article presents a translational framework for selecting, validating, and responsibly extending Leupeptin-based workflows while distinguishing established evidence from cross-domain opportunity.

• Triiodothyronine T3 for Adipose Thermogenesis

  2026-08-22

  Use Triiodothyronine as a reversible thyroid hormone signaling probe to test thermogenic capacity, receptor-dependent gene regulation, and metabolic phenotypes in adipocyte models. Its combination with SETD7 perturbation creates a practical framework for separating endocrine effects from epigenetic control of white adipose browning.

• LG 101506 (RXR Modulator) Workflow Guide

  2026-08-21

  Build a disciplined RXR signaling workflow around LG 101506, from stock preparation and reporter assays to orthogonal validation in immune-cold tumor models. The guide also shows how to translate the RBMS1–PD-L1 findings from triple-negative breast cancer research into testable assay choices without overstating evidence for RXR involvement.

• mCherry mRNA as a Delivery Assay Control

  2026-08-20

  Learn how mCherry mRNA can function as more than a fluorescent marker: it can separate nanoparticle delivery, cytosolic release, and translation performance. This guide connects Cap 1 design and modified nucleotides with practical assay decisions informed by kidney-targeted mRNA nanoparticle research.

447 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page